Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Use of Claims Data for Cost and Cost-Effectiveness Research
Ya Chen Tina Shih,
Lei Liu
Institute for Informatics, Data Science and Biostatistics (I2DB)
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute for Public Health
DBBS - Biomedical Informatics and Data Science
Rheumatic Diseases Research Resource-Based Center
Research output
:
Contribution to journal
›
Article
›
peer-review
17
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Use of Claims Data for Cost and Cost-Effectiveness Research'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Claims Data
100%
Cost-effectiveness Research
100%
Cost of Illness
50%
Cost Comparison
50%
Regression Model
25%
Procedure Codes
25%
Diagnostic Codes
25%
Medical Treatment
25%
Clinical Diagnosis
25%
Phase of Care
25%
Medical Conditions
25%
Analytical Method
25%
Cost-effectiveness Analysis
25%
Economic Evaluation
25%
Oncology
25%
Methodological Challenges
25%
Big Data
25%
Clinical Procedures
25%
Costing Methods
25%
Propensity Score Matching
25%
Research Evaluation
25%
Economic Study
25%
Cost-effectiveness Study
25%
Administrative Claims Data
25%
Introductory Overview
25%
Care Approach
25%
Cost-of-illness Study
25%
Care Relationship
25%
Net Benefit Regression
25%
Insurance Payments
25%
Medicine and Dentistry
Cost-Effectiveness Analysis
100%
Health Care Cost
100%
Cost of Illness
66%
Procedure Code
33%
Oncology
33%
Diagnosis Code
33%
Effectiveness Study
33%
Propensity Score Matching
33%
Evaluation Research
33%
Social Sciences
Cost-Effectiveness Analysis
100%
Diseases
66%
Evaluation Research
33%
Economic Studies
33%
Economic Evaluation
33%
Propensity Score
33%
Big Data
33%
Economics, Econometrics and Finance
Propensity Score Matching
100%
Cost-Effectiveness Analysis
100%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Effectiveness Study
50%